|
|
Volumn 95, Issue 24, 2003, Pages 1820-1821
|
|
Epoetin for cancer patients: A boon or a danger?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
HEMOGLOBIN;
PACLITAXEL;
PROTEIN BCL 2;
RECOMBINANT ERYTHROPOIETIN;
VASCULOTROPIN;
ZIDOVUDINE;
ANEMIA;
BREAST CANCER;
CANCER CONTROL;
CANCER GROWTH;
CANCER MORTALITY;
CANCER PALLIATIVE THERAPY;
CANCER PATIENT;
CANCER RESEARCH;
CANCER SURVIVAL;
CLINICAL TRIAL;
DRUG MARKETING;
DRUG SAFETY;
ERYTHROPOIESIS;
FATIGUE;
HEAD AND NECK CANCER;
HEMOGLOBIN DETERMINATION;
HUMAN;
MALIGNANT TRANSFORMATION;
METASTASIS;
NOTE;
PRIORITY JOURNAL;
QUALITY OF LIFE;
SURVIVAL RATE;
UPREGULATION;
|
|
EID: 0346098023
PISSN: 00278874
EISSN: None
Source Type: Journal
DOI: 10.1093/jnci/95.24.1820 Document Type: Note |
|
Times cited : (15)
|
|
References (0)
|